Predicted to enable CCR2 chemokine receptor binding activity; heparin binding activity; and lipopolysaccharide binding activity. Predicted to be involved in innate immune response. Predicted to be located in membrane; microvesicle; and nucleus. Orthologous to several human genes including DEFB106B (defensin beta 106B).
RGD Description
Predicted to enable CCR2 chemokine receptor binding activity; heparin binding activity; and lipopolysaccharide binding activity. Predicted to be involved in innate immune response. Predicted to be located in membrane; microvesicle; and nucleus. Orthologous to several human genes including DEFB106B (defensin beta 106B); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine (ortholog); aflatoxin B1 (ortholog); benzo[a]pyrene (ortholog).